ATE211919T1 - Gammainterferon enthaltende zusammensetzung zur prurigo-behandlung - Google Patents

Gammainterferon enthaltende zusammensetzung zur prurigo-behandlung

Info

Publication number
ATE211919T1
ATE211919T1 AT96114294T AT96114294T ATE211919T1 AT E211919 T1 ATE211919 T1 AT E211919T1 AT 96114294 T AT96114294 T AT 96114294T AT 96114294 T AT96114294 T AT 96114294T AT E211919 T1 ATE211919 T1 AT E211919T1
Authority
AT
Austria
Prior art keywords
prurigo
treatment
ifn
gamma
gammainterferon
Prior art date
Application number
AT96114294T
Other languages
English (en)
Inventor
Masahiro Takigawa
Yoshiki Tokura
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE211919T1 publication Critical patent/ATE211919T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96114294T 1995-09-07 1996-09-06 Gammainterferon enthaltende zusammensetzung zur prurigo-behandlung ATE211919T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26458295A JP3834084B2 (ja) 1995-09-07 1995-09-07 痒疹治療剤

Publications (1)

Publication Number Publication Date
ATE211919T1 true ATE211919T1 (de) 2002-02-15

Family

ID=17405301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96114294T ATE211919T1 (de) 1995-09-07 1996-09-06 Gammainterferon enthaltende zusammensetzung zur prurigo-behandlung

Country Status (6)

Country Link
US (1) US5972365A (de)
EP (1) EP0761228B1 (de)
JP (1) JP3834084B2 (de)
AT (1) ATE211919T1 (de)
DE (1) DE69618511T2 (de)
ES (1) ES2171585T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1582216A4 (de) * 2002-12-26 2010-04-21 Asubio Pharma Co Ltd Heilmittel für pemphigoid
US8490578B2 (en) 2009-10-13 2013-07-23 Pet Care Systems, Inc. Clumped sorbent material

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
DE3531597A1 (de) * 1985-09-04 1987-03-05 Bioferon Biochem Substanz Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung psoriatischer erkrankungen
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
DK0502997T3 (da) * 1989-12-01 1995-07-17 Childrens Medical Center Behandling af atopiske sygdomme med gamma-interferon
US5200177A (en) * 1989-12-01 1993-04-06 The Children's Medical Center Corporation Treatment of atopic disorders with gamma-interferon
TW218846B (de) * 1992-04-07 1994-01-11 Ciba Geigy

Also Published As

Publication number Publication date
US5972365A (en) 1999-10-26
DE69618511D1 (de) 2002-02-21
ES2171585T3 (es) 2002-09-16
DE69618511T2 (de) 2002-08-01
JP3834084B2 (ja) 2006-10-18
EP0761228A3 (de) 1997-06-25
JPH0971538A (ja) 1997-03-18
EP0761228B1 (de) 2002-01-16
EP0761228A2 (de) 1997-03-12

Similar Documents

Publication Publication Date Title
CA2181048A1 (en) A method for sustained and extended corneal analgesia
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
HU913447D0 (en) Medical preparations and their use in treating neurologic disorders
GB9519661D0 (en) Fatty acid treatment
EP0724885A4 (de) Pernasale zusammensetzung und diese enthaltende pernasale zubereitung
KR950703951A (ko) 광학적으로 순수한 r-케토로락을 포함하는 조성물과 무통과 해열치료에 이를 사용하는 방법(antipyretic and analgesic methods and compositions containing optically pure r-ketorolac)
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
ES2175333T3 (es) Nueva administracion de trombopoyetina.
NO931886L (no) Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
ZA95150B (en) Application of riluzole in the treatment of mitochondrial diseases
ATE211919T1 (de) Gammainterferon enthaltende zusammensetzung zur prurigo-behandlung
JPS6483020A (en) Medicinal composition for preventing or treating aids
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
KR950702433A (ko) Tcf-ii를 유효성분으로 하는 혈장 응고 정상화제
HK1005168A1 (en) Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident
Mira et al. Treatment of pharyngitis and pharyngolaryngitis. Comparison of phenylprenazone and flurbiprofen(froben) administered orally and rectally.
KR930019207A (ko) 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도
Aiello et al. Evaluation of efficacy, tolerableness and safety of Enalapril(in single daily dose in patients with mild essential hypertension).
ATE122889T1 (de) Verwendung von mizoribin zur behandlung oder vorbeugung der multiplen sklerose.
SU1807595A1 (ru) Средство для лечения отравлений ртутью
RU95102346A (ru) Способ лечения дисциркуляторной энцефалопатии
RU94018748A (ru) Лекарственный сбор для лечения больных с нарушениями сердечного ритма
葛通远 et al. AN APPROACH TO THE MECHANISMS OF LASER ACUPUNCTURE IN TREATMENT OF EXOPHTHALMIC HYPERTHYROIDISM

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties